Market size, share and growth analysis by technology, application and end users, with forecasts for 2023–2032. The competitive landscape profiles 15+ companies, including Roche Diagnostics Corporation, Thermo Fisher Scientific Inc. and Abbott Laboratories.
The North America tissue diagnostics market was valued at USD 2.5 Bn in 2023 and is projected to reach USD 4.7 Bn by 2032, growing at a CAGR of 7%.
Reports Description
As per the current market research conducted by the CMI Team, the North America Tissue Diagnostics Market is expected to record a CAGR of 7% from 2023 to 2032. In 2023, the market size is projected to reach a valuation of USD 2.5 Billion. By 2032, the valuation is anticipated to reach USD 4.7 Billion.
North America Tissue Diagnostics Market 2023–2032 (By Billion)
The North America Tissue Diagnostics Market encompasses the industry involved in the diagnosis of diseases through the examination of tissues. It includes a range of diagnostic methods, such as histology, cytology, and immunohistochemistry, to analyze tissue samples for identifying abnormalities and diseases.
Key players in this market provide diagnostic tools, equipment, and services, contributing to advancements in personalized medicine, early disease detection, and precision diagnostics.
Factors influencing the market include technological innovations, a focus on automation, and a growing aging population. The market plays a pivotal role in improving healthcare outcomes by enabling accurate and timely diagnoses for effective patient care.
North America Tissue Diagnostics Market - Significant Growth Factors
Technological Advancements: Continuous innovations in diagnostic technologies, including advanced imaging techniques and automation, drive the growth of the tissue diagnostics market by enhancing accuracy and efficiency in disease detection.
Increasing Incidence of Chronic Diseases: The rising prevalence of chronic diseases, such as cancer, fuels the demand for tissue diagnostics as it plays a crucial role in early detection and precise diagnosis, contributing to improved treatment outcomes.
Aging Population: The demographic shift towards an aging population in North America is a significant driver, leading to a higher incidence of age-related diseases and an increased demand for tissue diagnostics for effective disease management.
Rising Awareness and Patient Demand: Growing awareness among patients about the importance of early diagnosis and personalized medicine boosts the demand for tissue diagnostics services, prompting healthcare providers to expand their offerings.
Telehealth Integration: The increasing adoption of telehealth services presents an opportunity to integrate tissue diagnostics into remote healthcare delivery, enhancing accessibility to diagnostic services and improving patient outcomes.
Collaboration and Research Opportunities: Collaborations between industry players and research institutions present opportunities for developing and implementing innovative diagnostic solutions, fostering advancements in tissue diagnostics for improved patient care.
Government Initiatives and Funding: Supportive government initiatives, including funding for healthcare infrastructure and research projects, act as a driver for the tissue diagnostics market. Increased financial backing and favorable policies create an environment conducive to innovation and market expansion.
Collaborations and Strategic Partnerships: Collaborative efforts between healthcare institutions, diagnostic companies, and technology firms drive market growth. Strategic partnerships facilitate the development of integrated solutions, combining diagnostic technologies with healthcare systems, thereby enhancing the overall efficiency and accessibility of tissue diagnostics services.
North America Tissue Diagnostics Market - Mergers and Acquisitions
The North America Tissue Diagnostics Market has seen several mergers and acquisitions in recent years, with companies seeking to expand their market presence and leverage synergies to improve their product offerings and profitability. Some notable examples of mergers and acquisitions in the North America Tissue Diagnostics Market include:
In 2023, Agilent Technologies, Inc. partnered with Akoya Biosciences, Inc. to co-develop multiplex immunohistochemistry (IHC) diagnostic solutions. This collaboration aims to commercialize workflow solutions for multiplex assays in tissue analysis, offering an advanced multiplex IHC solution for biomarker clinical research, leveraging the capabilities of digital pathology.
In 2021, Roche introduced the DISCOVERY Green HRP Chromogen Detection Kit, aiming to broaden immunohistochemistry multiplexing capabilities in cancer research. This kit enhances the detection of multiple biomarkers simultaneously, facilitating more comprehensive and detailed analysis in the field of cancer diagnostics and research.
These mergers and acquisitions have helped companies expand their product offerings, improve their market presence, and capitalize on growth opportunities in the North America Tissue Diagnostics Market. The trend is expected to continue as companies seek to gain a competitive edge in the market.
COMPARATIVE ANALYSIS OF THE RELATED MARKET
North America Tissue Diagnostics Market
India Hospital Furniture Market
India IVF Services Market
CAGR 7% (Approx)
CAGR 9.23% (Approx)
CAGR 16.23% (Approx)
USD 4.7 Billion by 2032
USD 909.6 Million by 2032
USD 5,051.3 Million by 2032
North America Tissue Diagnostics Market - Significant Threats
The North America Tissue Diagnostics Market faces several significant threats that could impact its growth and profitability in the future. Some of these threats include:
Regulatory Challenges: Evolving and stringent regulatory requirements in the healthcare sector pose a significant threat to the North America Tissue Diagnostics Market. Compliance with changing regulations may increase operational costs and create hurdles in product approvals and market entry.
High Implementation Costs: The initial costs associated with implementing advanced tissue diagnostic technologies and maintaining up-to-date equipment can be substantial. This financial barrier may limit the adoption of advanced diagnostic solutions, especially for smaller healthcare facilities, impacting market growth.
Data Security Concerns: The increasing reliance on digital platforms and electronic health records raises concerns about data security and patient privacy. Cybersecurity threats and data breaches can undermine confidence in tissue diagnostics technologies, potentially affecting market acceptance and adoption.
Supply Chain Disruptions: The tissue diagnostics market relies on a complex global supply chain for reagents, equipment, and consumables. Disruptions in the supply chain, whether due to geopolitical events, natural disasters, or global health crises, can adversely impact the availability of essential components, leading to market constraints.
Competition from Alternative Diagnostic Methods: Emerging alternative diagnostic methods, such as liquid biopsies and molecular diagnostics, pose a threat to traditional tissue diagnostics. These alternatives offer less invasive approaches, potentially diverting demand away from traditional tissue-based diagnostic methods and affecting market share.
Category-Wise Insights
By Technology:
In Situ Hybridization (ISH): In Situ Hybridization involves detecting specific DNA or RNA sequences in tissue sections. In North America, ISH is witnessing increased adoption of precise genetic analysis in cancer. Trends include expanded use in molecular pathology, aiding targeted therapies, and its application in personalized medicine.
Immunohistochemistry (IHC): Immunohistochemistry identifies antigens in tissues using antibodies. In North America, IHC is pivotal for cancer diagnosis. Trends include automation for efficiency, biomarker discovery, and its integral role in companion diagnostics for targeted therapies.
Digital Pathology and Workflow: Digital Pathology employs digital tools for managing and interpreting pathology information. In North America, it's evolving with trends in AI integration, remote diagnostics, and enhanced collaboration, improving diagnostic accuracy and streamlining workflows for pathologists.
Primary and Special Staining: Primary and Special Staining involve coloration of tissues for microscopic examination. In North America, these traditional methods persist. Trends include automation for efficiency, standardization for reproducibility, and novel stains for enhanced diagnostic information.
Anatomic Pathology: Anatomic Pathology focuses on studying tissues for disease diagnosis. In North America, trends include increasing demand for subspecialty expertise, technological integration for efficiency, and a growing role in personalized medicine advancements.
By Application
Prostate Cancer: Prostate cancer tissue diagnostics involve examining prostate tissue for cancerous abnormalities. Trends in North America include the increasing adoption of multiparametric magnetic resonance imaging (mpMRI) for precise diagnoses and the development of biomarkers, enhancing early detection and personalized treatment strategies.
Breast Cancer: Breast cancer tissue diagnostics analyze breast tissue for malignancies. North America sees a trend towards advanced molecular testing, like HER2/neu testing and gene expression profiling. This aids in accurate subtype identification, guiding targeted therapies and improving overall breast cancer management.
Lung Cancer: Tissue diagnostics for lung cancer involve analyzing lung tissue for abnormalities. In North America, a trend involves the integration of liquid biopsy techniques alongside traditional tissue biopsies for comprehensive genetic profiling. This enhances early detection and treatment decisions for lung cancer.
Gastric Cancer: Gastric cancer tissue diagnostics focus on examining stomach tissue for cancer. In North America, a trend includes the application of immunohistochemistry and molecular testing to identify specific markers, guiding personalized treatment approaches. This enhances diagnostic accuracy and treatment planning for gastric cancer.
Other Cancer: Tissue diagnostics for various cancers beyond the specified categories involve analyzing tissue samples for malignancies. Trends include the integration of artificial intelligence in pathology for faster and more accurate diagnoses, contributing to improved patient outcomes and personalized treatment strategies.
By End User
Research Laboratories: Research laboratories in North America Tissue Diagnostics Market conduct in-depth studies to develop and enhance diagnostic technologies. Trends include a focus on molecular diagnostics, automation for efficiency, and collaborative projects with industry players to advance diagnostic capabilities.
Hospitals: Hospitals are crucial end-users in the Tissue Diagnostics Market, providing diagnostic services to patients. Trends include the integration of digital pathology, point-of-care diagnostics, and a shift towards personalized medicine for more effective patient care.
Contract Research Organizations (CROs): Contract Research Organizations play a pivotal role in clinical research and drug development, utilizing tissue diagnostics for robust trial outcomes. Trends involve increased outsourcing of diagnostic services, adoption of advanced imaging techniques, and customization of diagnostic solutions for research studies.
Pharmaceutical Organizations: Pharmaceutical organizations leverage tissue diagnostics to enhance drug development and clinical trials. Trends include a growing emphasis on companion diagnostics, biomarker identification for targeted therapies, and collaborations with diagnostic companies to streamline the drug development process.
Report Scope
Feature of the Report
Details
Market Size in 2023
USD 2.5 Billion
Projected Market Size in 2032
USD 4.7 Billion
Market Size in 2022
USD 2.4 Billion
CAGR Growth Rate
7% CAGR
Base Year
2023
Forecast Period
2024-2033
Key Segment
By Technology, Application, End Users and Region
Report Coverage
Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends
Regional Scope
North America
Buying Options
Request tailored purchasing options to fulfil your requirements for research.
Competitive Landscape – North America Tissue Diagnostics Market
These companies operate in the market through various strategies such as product innovation, mergers and acquisitions, and partnerships.
Emerging players such as Guardant Health and Foundation Medicine are adopting innovation to enter the North America Tissue Diagnostics Market. They focus on liquid biopsy technologies, next-generation sequencing, and artificial intelligence for enhanced diagnostic precision and efficiency, catering to evolving healthcare demands.
Established leaders like Roche Diagnostics, Thermo Fisher Scientific, and Danaher Corporation dominate the North America Tissue Diagnostics Market. Their market dominance is attributed to extensive R&D, diverse product portfolios, strategic acquisitions, and strong collaborations, ensuring a comprehensive and technologically advanced suite of tissue diagnostic solutions.
Which are the driving factors of the North America Tissue Diagnostics Market?
The key factors driving the Market are Technological Advancements, Increasing Incidence of Chronic Diseases, Aging Population, Rising Awareness and Patient Demand, Telehealth Integration, Collaboration and Research Opportunities And Government Initiatives and Funding.
Which type led the North America Tissue Diagnostics market?
The "In Situ Hybridization" category dominated the market in 2022.
Who are the key players in the North America Tissue Diagnostics market?
The key players in the market are Roche Diagnostics Corporation, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Agilent Technologies Inc., Bio-Rad Laboratories Inc., Siemens Healthineers, Leica Biosystems Nussloch GmbH , Becton, Dickinson and Company (BD), Sysmex Corporation, Illumina Inc., PerkinElmer Inc., Merck KGaA, Cell Signaling Technology Inc., Hologic Inc., Others.
What is the growth rate of the North America Tissue Diagnostics market?
The global market is projected to grow at a CAGR of 7% during the forecast period, 2023-2032.
How much is the North America Tissue Diagnostics market?
The North America Tissue Diagnostics Market size was valued at USD 2.5 Billion in 2023.
Ayush Kadam is a Senior Market Research Analyst at Custom Market Insights, with over seven years of experience in syndicated and custom market research. He specializes in market sizing, competitive intelligence, industry trends, forecasting, and strategic insights, helping clients turn complex data into actionable business decisions.
